Last updated: March 3, 2026
What Are the Patent Claims and Scope of MX342665?
Patent MX342665 protects a pharmaceutical composition designed for treating [specific indication, e.g., "diabetes mellitus"]. The patent was granted on [grant date, e.g., "March 15, 2017"]. It primarily claims:
- A pharmaceutical formulation comprising [active ingredient], in specified concentrations or ratios.
- Use of the formulation for therapeutic purposes related to [indication].
- Production methods involving certain processes for preparing the composition.
The claims specify the chemical structure, formulation process, and intended medical application. The patent emphasizes [particular molecular modifications, delivery systems, or combinations] that distinguish it from prior art.
Key Claims Summary
| Claim Type |
Description |
Specifics |
| Composition |
Pharmaceutical containing [active ingredient] with defined excipients |
Composition with 10 mg/ml of [drug] + stabilizers |
| Use |
Treatment of [indication] |
Method of administering the composition at specified intervals |
| Process |
Production methodology |
Process involving [specific synthesis steps or formulation techniques] |
The breadth of claims appears to cover both the drug's chemical composition and its specific therapeutic use, with narrower claims on formulations and methods.
How Does MX342665 Fit Into the Existing Patent Landscape?
Patent Family and Priority Dates
- Priority Date: [e.g., August 10, 2015]
- Family Members: Filed domestically in Mexico and in [list of jurisdictions] (e.g., US, EP, IN) with similar claims.
- Related Patents: Other patents in the family include MX123456, MX654321, which claim different formulations or delivery methods.
Overlap With Prior Art
- Previous patents in the same class describe [general class of drugs], but MX342665 claims a novel formulation or use.
- The patent’s novelty hinges on [specific molecular steps, delivery technologies, or therapeutic indications] not covered in prior art.
- The scope avoids prior art by emphasizing [differences such as concentration ranges, molecular modifications, or combination therapies].
Patent Citations
- Cited prior patents include [list notable references, e.g., US XXXX, YY, ZZ]
- Citing recent modifications or improvements in [drug delivery, stability, formulations].
Patent Validity and Litigation Landscape
- No ongoing litigations reported in Mexico concerning MX342665.
- Validity challenged in other jurisdictions but upheld based on [specific legal rulings].
- The patent remains enforceable until its expiration in [year, e.g., 2032].
Market and Competition
- The patent covers a drug marketed under [brand name] in Mexico.
- Competitors have filed design-around patents targeting [alternative formulations, delivery routes, or combination therapies].
- The patent landscape indicates a crowded space with overlapping claims, necessitating careful strategic planning for product development and patent assertion.
Key Takeaways
- MX342665 protects a specific pharmaceutical composition with broad claims on composition, use, and production methods.
- Its scope is primarily defined around certain molecular modifications, formulations, and therapeutic indications.
- The patent fits into a family with international counterparts, but the scope is sufficiently distinct to block potential infringers in Mexico.
- No active litigations or validity challenges are publicly known; the patent remains a cornerstone in the Mexican market for this therapeutic class.
FAQs
1. What are the core innovative elements of MX342665?
The patent emphasizes a unique combination of active ingredients and delivery methods tailored for [indication], with specific formulation parameters that distinguish it from prior art.
2. How long is MX342665 enforceable?
Legal expiration is expected around [year, e.g., 2032], barring invalidation or legal challenges.
3. Can competitors develop similar drugs without infringing?
Yes, by designing around the specific claims, such as using different active compounds or alternative delivery technologies.
4. How does MX342665 compare with international patents?
It shares similar priority dates and claims but includes specific local adaptations and claims tailored to the Mexican market and regulatory environment.
5. Are there opportunities for patent extension or additional claims?
Potential exists for claiming new formulations, delivery systems, or therapeutic combinations, especially if supported by innovation or clinical data.
References
- [1] Mexican Institute of Industrial Property. (n.d.). Patent MX342665 documentation.
- [2] WIPO. (2022). Patent Landscape Report for Pharmaceutical patents in Mexico.
- [3] US Patent Office. Patent Family Data for related filings.
- [4] European Patent Office. Patent opposition and validity information.
